Abstract

N-acetylglucosaminyltransferase V (GnT-V) is one of the most relevant glycosyltransferases to tumor invasion and metastasis. Based on previous findings of molecular recognition between GnT-V and synthetic substrates, we designed and synthesized a p-iodophenyl-derivatized trisaccharide, 2-(4-iodophenyl)ethyl 6-O-[2-O-(2-acetamido-2-deoxy-β-d-glucopyranosyl)-α-d-mannopyranosyl]-β-d-glucopyranoside (IPGMG, 1) and its radiolabeled form, [125I]IPGMG ([125I]1), for use in assays of GnT-V activity in vitro. The tributyltin derivative, 2-[4-(n-tributylstannyl)phenyl]ethyl 6-O-[2-O-(3,4,6-tri-O-acetyl-2-acetamido-2-deoxy-β-d-glucopyranosyl)-3,4,6-tri-O-acetyl-α-d-mannopyranosyl]-2,3,4-tri-O-acetyl-β-d-glucopyranoside (21), was synthesized as a precursor for the preparation of [125I]1. The iododestannylation of 21 using hydrogen peroxide as an oxidant followed by deacetylation yielded [125I]1. When [125I]1 was incubated in GnT-V-expressing cells with a UDP-GlcNAc donor, the production of β1–6GlcNAc-bearing IPGMG (IPGGMG, 2) was confirmed by radio-HPLC. In kinetic analysis, 1 was found to be a good substrate with a Km of 23.7μM and a Vmax of 159pmol/h. μg protein. [125I]1 would therefore be a useful synthetic substrate for the quantitative determination of GnT-V activity.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call